Novartis and FDA notified healthcare professionals of changes to the WARNINGS and ADVERSE REACTIONS sections of the product labeling for Exjade, a drug used to treat chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older.
Jet lag, a disruption of bodily rhythms caused by high-speed travel across several time zones typically in a jet aircraft, may be treated with viagra – a well-known impotence drug, revealed by Argentine researchers.
New data demonstrated that the combination asthma therapy, SYMBICORT? (budesonide/formoterol fumarate dihydrate), led to significant improvements in health-related quality of life (HRQL) and greater patient-reported satisfaction with asthma treatment, versus its monocomponents (budesonide or formoterol) or placebo.
A minimally invasive device for treating recurrent stress urinary incontinence in women has been shown to be safe and effective in early clinical trials and is now under review by the US Food and Drug Administration (FDA), says Emory University School of Medicine urologist and trial co-principal investigator Niall Galloway, MD.
Scientists have made a breakthrough in understanding how cancers spread in what could lead to new ways of beating the disease.
In adults with major depressive disorder, adding aripiprazole to antidepressant therapy (ADT) resulted in significant improvement in the primary endpoint, the Montgomery-Asberg Depression Rating Scale (MADRS) Total Score.
Treating skin wounds with a concentrated topical gel of the patient’s own blood platelets may result in faster healing, says a researcher at the University of Cincinnati (UC).
GlaxoSmithKline [NYSE:GSK] issued the following response to an article in the New England Journal of Medicine (NEJM) on Avandia? (rosiglitazone maleate), a widely used and highly effective treatment for type 2 diabetes:
NewYork-Presbyterian Hospital/Weill Cornell Medical Center urologists are presenting exciting new research at the 2007 American Urological Association (AUA) Conference in Anaheim, May 19?May 24. Among the most significant presentations are the following:
Cystoplasty using gastrointestinal segments is a common treatment for patients with end-stage bladder disease.